
New tool spots early signs of infection after breast cancer reconstruction
Researchers at Washington University School of Medicine in St. Louis have developed a new tool to detect reconstruction-related infections early, before they cause symptoms.

Researchers at Washington University School of Medicine in St. Louis have developed a new tool to detect reconstruction-related infections early, before they cause symptoms.

Researchers from the Institute of Industrial Science, The University of Tokyo have used 3D-printing technology to improve the viral titer of microneedle array patches, resulting in effective immunogenicity and protection against infection in mice.

A research team led by Professor Víctor Yuste, from the Department of Biochemistry and Molecular Biology and the Institut de Neurociències de la UAB (INc-UAB), has designed and tested several bioadhesive patches that could be placed at the site where the tumor is removed during surgery, targeting any remaining cancer cells.

Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.

Next-generation vascular stents can make cardiovascular therapies minimally invasive and vascular treatments safe and less burdensome.

A new type of brain implant may have implications for both brain research and future treatments of neurological diseases such as epilepsy.

A study led by Dartmouth Engineering professors demonstrates a possible new technique for connecting electronic implants with the surface of the brain, as well as a new method for ensuring safe, long-term medical access to the brain.

An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as “bad” cholesterol, by up to 60%, according to a new phase three clinical trial published in the New England Journal of Medicine.

Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials.

OKLAHOMA CITY, Feb. 4, 2026 /PRNewswire/ — Acarix today announced its CADScor®System has successfully achieved certification under the European Union Medical Device Regulation (EU MDR 2017/745).